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Summary Alterations of microsatellites have been found at relatively high frequency in hereditary and sporadic colorectal cancer and gastric
and pancreatic cancers and at lowerfrequency in some other cancers. We determined the frequency of instability at 39 poly-CA microsatellite
loci in 20 squamous cell carcinomas and 26 Barrett's adenocarcinomas of the oesophagus. None of the tumours presented instability for a
high percentage of the tested loci. Four squamous cell carcinomas and six Barrett's adenocarcinomas showed microsatellite instability at one
locus, and three Barrett's adenocarcinomas showed microsatellite instability at two loci. The presence of few loci showing microsatellite
instability could be due to an instability background. We conclude that genetic defects in the DNA mismatch repair system do not play an
important role in oesophageal cancers.
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Recently a new class of genetic alterations in human tumours has
been described (Aaltonen et al, 1993; Thibodeau et al, 1993).
These appear at microsatellite loci that are short, repeated
nucleotide sequences distributed within the normal genome.
Alterations of microsatellites consist of the loss or gain of one or
more repeat units in tumours compared with matched normal
DNA and have been termed microsatellite instability (MI). MI was
first described in colorectal cancer, in both hereditary non-poly-
posis colorectal cancer (HNPCC) and sporadic colorectal cancer
cases (Aaltonen et al, 1993; Thibodeau et al, 1993), as a result ofa
deficient DNA mismatch repair system (Fishel et al, 1993; Leach
et al, 1993; Parsons et al, 1993; Bronner et al, 1994; Nicolaides et
al, 1994; Papadopoulos et al, 1994). MI has also been observed in
a variety of sporadic cancers, such as endometrium, stomach,
kidney, ovary and pancreas cancers, belonging to the HNPCC
tumour spectrum (Han et al, 1993; Peltomaki et al, 1993; Risinger
et al, 1993). In bladder, breast and lung cancers, MI has been
reported with variable frequency (Gonzalez-Zulueta et al, 1993;
Merlo et al, 1994; Schridar et al, 1994). There are conflicting
reports concerning the presence of MI in oesophageal cancers
(Meltzer et al, 1994; Keller et al, 1995; Mironov et al, 1995;
Nakashima et al, 1995; Gleeson et al, 1996). Cancerofthe oesoph-
agus is among the most common and severe malignant neoplasms
in the world (Muller et al, 1990; Parkin et al, 1993). There are two
main histological types of oesophageal cancer, squamous cell
carcinoma (SCC) and Barrett's adenocarcinoma (BA). SCC is
more frequent and is associated with alcohol and tobacco
consumption in Western countries (Tomatis et al, 1990). BA
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develops in Barrett's oesophagus (Spechler and Goyal, 1986), an
acquired metaplastic process resulting from chronic gastro-
oesophageal reflux (Potet and Duchatelle, 1990). The mechanisms
of carcinogenesis of the oesophageal mucosa are not entirely
established.
In this study, we compared the incidence ofMI in the two main
types of oesophageal cancer and compared our results with those
obtained in other series.
MATERIALS AND METHODS
Tumours and DNA
Fresh resected specimens were collected during surgery at
Beaujon Hospital (Clichy, France) from 1988 to 1994. Twenty
SCCs and 26 BAs were included in the study. The patients had
received neither radiation therapy nor chemotherapy before
surgery. In all cases part of the tumour and part of the normal
gastric mucosa were snap frozen and stored at -80°C until use.
The surgical specimen was embedded in paraffin for histopatho-
logical analysis. The group of patients with SCC demonstrated a
male-female ratio of 17:3 and a median age at diagnosis of 58
years (range, 44-72 years). In the patients with BA, the
male-female ratio was 24:2 and the median age at diagnosis was
65 years (range 42-80 years). Consumption ofalcohol and tobacco
was known for 18 patients with SCC and 24 patients with BA; 15
patients with SCC (83%) and four with BA (17%) were chronic
alcoholics; 14 patients with SCC (78%) and 15 with BA (58%)
were smokers.
Genomic DNA was extracted from primary tumours and adja-
cent normal gastric mucosa by proteinase K digestion and
phenol-chloroform extraction as described previously (Sambrook
et al, 1989). p53 alterations had been searched previously in all
tumours studied (Muzeau et al, 1996).













Figure 1 Examples of microsatellite instability in oesophageal cancers at
different loci. N, normal DNA; T, tumour DNA
Table 1 Main clinical and morphological features of oesophageal carcinomas
included in the study
Squamous cell carcinoma Barrett's adenocarcinoma
(n =20) (n =26)
With no Ml With Ml at one With no Ml With Ml at
or two loci one or two loci
(n=16) (n=4) (n=17) (n=9)
Mean age (years) 58 59 65 64
Male-female 3:13 0:4 1:16 1:8
Alcoholic 12 (14a) 3(4a) 4 (16a) 0 (8a)
Smokers 11 (14a) 3(4a) 10 (16a) 4 (8a)
p53+b 15 3 16 8
UICC grade
6 3
Ila 5 4 2
Ilb 2 1
III 9 3 6 4
IV 1
Ml, microsatellite instability. Alcoholic, consumption of alcohol > 80 g per day;
smokers, consumption of tobacco > 20 packet-years. aPatients for whom
alcoholic and smoking habits are known. bp53+, Mutation of p53 gene and/or
accumulation of p53 protein (Muzeau et al, 1996).
Microsatellite instability
A total of 39 poly-CA microsatellite loci selected from among the
published list from Genethon (Gyapay et al, 1994) were analysed.
Four were located on chromosome 1 (D1S225, DlS229, D1S239,
D1S306), two on chromosome 3 (D3S1282, D3SI297), one on
chromosome 4 (D4S414), two on chromosome 5 (D5S393,
D5S430), three on chromosome 6 (D6S309, D6S271, D6S277),
three on chromosome 8 (D8S272, D8S277, D8S283), 14 on chro-
mosome 9 (D9S152, D9S153, D9S156, D9S157, D9S158,
D9S159, D9S161, D9S165, D9S168, D9S169, D9S171, D9S175,
D9S197, D9S259), two on chromosome 10 (DlOS199, D1OS226),
one on chromosome 13 (D13S175), one on chromosome 14
(D14S250), one on chromosome 15 (D15S128), one on chromo-
some 16 (D16S517), two on chromosome 17 (D17S784,
D17S790), one on chromosome 18 (D18S53) and one on chromo-
some 20 (D2OS107).
Primers specific for each locus were used to amplify the repeat
and short flanking sequences from template DNA using multiplex
polymerase chain reaction (PCR). Amplification was carried out in
a 9600 Perkin Elmer Cetus thermal cycler, using an AmpliTaq kit
(Perkin Elmer Cetus, Emeryville, CA, USA) in a final volume of
20 gl containing 25 ng of genomic DNA, 0.25 U of Taq poly-
merase, 0.3 ,umol 1-' of each primer, 20 gmol 1-' of each dNTP,
1.5 mmol 1- magnesium chloride and 1 x buffer. PCR was
performed for 35 cycles, each comprising 30 s at 94°C, 30 s at55°C
and 60 s at 72°C. Aliquots ofamplified DNA were electrophoresed
on a 6% polyacrylamide, 32% formamide, 7 mol 1-' ureadenaturing
gel and transferred onto Hybond nylon membranes. Filters were
hybridized with a 32P-labelled (CA)12 probe and autoradiographed.
RESULTS AND DISCUSSION
In this study, none of the tumours showed a high MI index. Four
of 20 SCCs showed MI at one locus (2.5% of 39 loci tested).
Among 26 BAs, six and three tumours showed MI at one (2.5%
of loci tested) and two loci (5% of loci tested) respectively.
Representative examples of MI are shown in Figure 1. The insta-
bility affected different loci on chromosome 3, 4, 6, 9, 17 and 18.
No MI was demonstrated in any ofthe remaining cases.
Table 2 Microsatellite instability in oesophageal cancers
Authors No. of tumours tested No. of loci tested No. of tumours with Ml at x% loci tested
< 10% 10% < Ml < 40% > 40%
Meltzer et al (1994) 36 BA 5 0 6 2
(USA) 42 SCC 0 1 0
Keller et al (1995) 15 BA 8 0 2 0
(Germany)
Mironov et al (1995) 18 SCC 17 2 0 0
(France)
Nakashima et al (1995) 29 SCC 5 0 4 2
(Japan)
Gleeson et al (1996) 17 BA 139 16 0 1
(Northern Ireland)
Present series 26 BA 39 8 0 0
(France) 20 SCC 4 0 0
Total 94 BA 24 (25%) 8 (8%) 3 (3%)
109 SCC 6 (6%) 5 (5%) 2 (2%)
Ml, microsatellite instability; BA, Barrett's adenocarcinoma; SCC, squamous cell carcinoma.
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The characteristics of the 13 (28%) tumours that showed MI at
one or two microsatellite loci compared with tumours without MI
are presented in Table 1.
An association between the presence of MI and certain clinico-
pathological features has been reported in sporadic colorectal
cancer (Lothe et al, 1993; Kim et al, 1994) and gastric cancer (Dos
Santos et al, 1996). However, forboth types oftumours, only those
carcinomas with multiple replication error positive (RER+) loci
were significantly associated with poor differentiation, rare nodal
metastases and prolonged survival, whereas carcinomas with one
or two loci instable were similar to RER- carcinomas (Lothe et al,
1993; Dos Santos et al, 1996). In our study, we also observed
no differences between tumours with MI at one or two loci and
those without instability, regarding their clinicopathological
characteristics (Table 1).
Moreover, in colon cancer, tumours with instability at multiple
loci were frequently diploid (Aaltonen et al, 1993). Although we
did not study the DNA ploidy in our tumours, it has been reported
that most oesophageal cancers have a DNA-aneuploid pattern
(Robaszkiewicz et al, 1991; Nakamura et al, 1994), a feature that
again suggests that those tumours do not behave as RER+ carci-
nomas. Altogether, it appears that our finding ofMI in a single or in
two loci does not imply a mutator phenotype for those tumours and
that multiple alterations at microsatellite loci as described in RER+
cancers is very unusual in both types ofoesophageal carcinomas.
We have found five series reporting MI in oesophageal cancer in
the literature (Table 2). Together with our study, they included a
total of 109 SCCs and 94 BAs (Meltzer et al, 1994; Keller et al,
1995; Mironov et al, 1995; Nakashima et al, 1995; Gleeson et al,
1996). Only the study by Meltzer et al (1994) and our series
included both types ofoesophageal cancer: SCC and BA.
Criteria for identifying RER+ tumours have not been precisely
defined. Hamelin et al (1994a), analysing a series ofcolon cancers
with more than 100 poly-CA microsatellite loci, found two types
oftumours. A first group oftumours located predominantly in the
right colon showed MI at more than 50% of loci tested and were
considered as RER+. A second group showed MI between 0% and
10% of loci tested and were considered as RER-. It could be
hypothesized that the presence of rare loci showing MI is
explained by the existence of a background of instability (<10%),
independent of genetic defects in the mismatch repair system.
Therefore, it is necessary to examine numerous loci to categorize a
tumour as RER+.
It is noteworthy from Table 2 that oesophageal tumours with an
instability index between 10% and 40% were detected only in
series analysed with a small number of microsatellites (Meltzer et
al, 1994; Keller et al, 1995; Nakashima et al, 1995) whereas, in
series analysed with at least 17 microsatellites (Mironov et al,
1995; Gleeson et al, 1996; present series), tumours had an insta-
bility index either below 10% or above 40%. This observation
suggests that there is also a background of MI in oesophageal
cancers and that only 3 out of 94 (3%) BA and 2 out of 109 (2%)
SCC are really RER+ tumours in the literature.
A number of genetic changes have been demonstrated in both
types of oesophageal cancer, including loss of heterozygosity
involving the loci for several tumour-suppressor genes, such as
Rb, p53, APC and DCC (Huang et al, 1992; Boyton et al, 1993).
Mutation of the p53 tumour-suppressor gene has been reported as
extremely frequent in BA (Hamelin et al, 1994b; Gleeson et al,
1995) and SCC (Audrezet et al, 1993; Muzeau et al, 1996). In
colorectal cancer, it appears that there is an inverse relationship
between the presence of p53 gene mutation and the RER+ pheno-
type (Kim et al, 1994; Cottu et al, 1996). Ifthe same phenomenon
occurs in oesophageal carcinogenesis, a high percentage of p53
mutation may make it unlikely to find tumours that are character-
istic ofthe RER+ phenotype.
We conclude that genetic defects in the DNA mismatch repair
system, responsible for the RER+ phenotype, do not play an impor-
tant role in oesophageal cancers.
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